Literature DB >> 19006567

Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia.

Christine J Harrison1.   

Abstract

Cytogenetics has determined the incidence and prognostic significance of chromosomal abnormalities in acute lymphoblastic leukaemia (ALL). The development of fluorescence in situ hybridization (FISH) and array technologies has led to the discovery of novel aberrations. Five 'hot topics' are presented in which cytogenetics and related techniques have been instrumental in understanding the role of genetics in leukaemogenesis: (i) genetic changes are integral to the biology of T-cell ALL; (ii) intrachromosomal amplification of chromosome 21 is a new recurrent abnormality in precursor-B ALL (BCP-ALL); (iii) the immunoglobulin heavy chain gene (IGH@) is significant in BCP-ALL; (iv) alterations in genes involved in B-cell development and cell cycle control contribute to the pathogenesis of BCP-ALL; (v) age-related cytogenetic profiles define ALL in children and adolescents as distinct biological entities. In this molecular era, cytogenetics continues to be integral to our understanding of the genetics of this disease.

Entities:  

Mesh:

Year:  2008        PMID: 19006567     DOI: 10.1111/j.1365-2141.2008.07417.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  56 in total

1.  Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.

Authors:  Suman Bhatia; Deepak Kaul; Neelam Varma
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

Review 2.  Genomic profiling of B-progenitor acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-06       Impact factor: 3.020

Review 3.  Blood consult: therapeutic strategy and complications in the adolescent and young adult with acute lymphoblastic leukemia.

Authors:  Taizo A Nakano; Stephen P Hunger
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

Review 4.  Emerging technologies in paediatric leukaemia.

Authors:  Amanda Dixon-McIver
Journal:  Transl Pediatr       Date:  2015-04

Review 5.  Long-term complications in adolescent and young adult leukemia survivors.

Authors:  K Scott Baker; Karen L Syrjala
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

6.  EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.

Authors:  Vivien Schäfer; Jana Ernst; Jenny Rinke; Nils Winkelmann; James F Beck; Andreas Hochhaus; Bernd Gruhn; Thomas Ernst
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-11       Impact factor: 4.553

7.  Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.

Authors:  Motohiro Kato; Atsushi Manabe; Katsuyoshi Koh; Takeshi Inukai; Nobutaka Kiyokawa; Takashi Fukushima; Hiroaki Goto; Daisuke Hasegawa; Chitose Ogawa; Kazutoshi Koike; Setsuo Ota; Yasushi Noguchi; Akira Kikuchi; Masahiro Tsuchida; Akira Ohara
Journal:  Int J Hematol       Date:  2014-06-18       Impact factor: 2.490

8.  Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic.

Authors:  Charles G Mullighan; Cheryl L Willman
Journal:  J Adolesc Young Adult Oncol       Date:  2011-06       Impact factor: 2.223

Review 9.  Acute lymphoblastic leukaemia.

Authors:  Hiroto Inaba; Mel Greaves; Charles G Mullighan
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321

10.  Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts.

Authors:  Sabina Chiaretti; Antonella Vitale; Gianni Cazzaniga; Sonia Maria Orlando; Daniela Silvestri; Paola Fazi; Maria Grazia Valsecchi; Loredana Elia; Anna Maria Testi; Francesca Mancini; Valentino Conter; Geertruy te Kronnie; Felicetto Ferrara; Francesco Di Raimondo; Alessandra Tedeschi; Giuseppe Fioritoni; Francesco Fabbiano; Giovanna Meloni; Giorgina Specchia; Giovanni Pizzolo; Franco Mandelli; Anna Guarini; Giuseppe Basso; Andrea Biondi; Robin Foà
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.